The work of Professor Fanny Mochel (AP-HP, Sorbonne University) at Paris Brain Institute, in collaboration with clinical research teams in eight countries and Spanish biotech Minoryx Therapeutics, has demonstrated the protective ...
Jan 20, 2023
0
65
US biotech company Moderna on Tuesday announced positive interim trial results for its vaccine against respiratory syncytial virus (RSV) in adults over the age of 60.
Jan 17, 2023
0
20
For patients with mild-to-moderate COVID-19, treatment with fluvoxamine does not improve time to sustained recovery versus placebo, according to a study published online Jan. 12 in Journal of the American Medical Association.
Jan 13, 2023
0
13
Guilt is an uncomfortable feeling and can be burdensome. Researchers at the University of Basel have shown that placebos can help reduce feelings of guilt, even when the placebo is administered openly.
Jan 12, 2023
0
56
Early in the pandemic, when people with COVID-19 began reporting that they lost their sense of smell, Zara Patel, MD, figured as much. A professor of otolaryngology at Stanford Medicine, Patel has, for years, studied loss ...
Jan 12, 2023
0
54
Postoperative delirium—a behavioral state characterized by confused thinking and a lack of awareness—occurs in 10–30% of older patients who are recovering from heart surgery, and it has been linked with long-term cognitive ...
Jan 6, 2023
0
9
Treating the painful shoulder condition adhesive capsulitis with a nerve block is a safe, simple and effective treatment, according to recent results from a Flinders-led clinical trial.
Dec 21, 2022
0
2
For patients newly diagnosed with Parkinson disease, deferiprone is associated with worse scores in measures of parkinsonism, according to a study published in the Dec. 1 issue of the New England Journal of Medicine.
Dec 1, 2022
0
4
Researchers at Karolinska Institutet in Sweden have conducted a pioneering study analyzing internet-delivered anonymous cognitive behavioral therapy (CBT) for people who view images or videos of children being sexually abused. ...
Nov 30, 2022
0
28
Eisai Co. unveiled much-anticipated findings on its experimental Alzheimer's drug, providing tinder for the hot debate over whether its modest efficacy is worth potential risks that include serious brain bleeding.
Nov 30, 2022
0
11
